DERANGED THYROID HORMONE STATUS IN NON-THYROID ILLNESSES; SICK EUTHYROID SYNDROME

Authors

  • Tariq Saeed Mufti
  • Asif Jielani

Abstract

Critical illness is characterized by multiple andcomplex metabolic, immunological and endocrinealterations1. Abnormalities in thyroid homeostasis alsooccur in variety of non-thyroid illnesses. Changes inthyroid hormone metabolism in critical illnessesappear to reflect a continuum which relates primarilyto the severity of the underlying disorders2,3. Theprevalence of one or more abnormalities of thyroidfunction tests in patients with non thyroidal medicalillnesses has been reported from 40% to 70%4,5. Thecondition is reported in starvation6, sepsis 7, surgery 8,myocardial infarction9, CABG surgery 10, bone marrowtransplantation11, and, in fact, probably any severeillness.Girvent et al12 noted that such changes arehighly prevalent in elderly patients with acute surgicalproblems, and is associated with poor nutrition andhigher sympathetic response. The general hormonalresponse to critical illness involves activation of thepituitary-adrenal axis, inhibition of the pituitarythyroid & pituitary- gonadal axes13. These normalresponses distort standard reference intervals. In caseof the pituitary-thyroid axis, evaluation is furthercomplicated by changes in nutrition and major effectsof medication. Evidence suggests that these patientsmay not really be euthyroid, especially at the tissuelevel14.Based upon the fact that patients with systemicillness are clinically euthyroid, Wartofsky andBunnan15 in 1982 used the term sick euthyroidsyndrome to describe spectrum of thyroidabnormalities associated with non thyroidal illness.Euthyroid Sick Syndrome (ESS) and Non thyroidalillness syndrome (NITS) are terms used alternativelyin the literature16,17.The interpretational difficulty due to NTISleading to mismanagement of co-existing goiter, apathology of sizable incidence in certain geographicaldistribution including Pakistan, is a significantpossibility.Initial data of thyroid function tests fromInstitute of Nuclear Medicine, Oncology andRadiotherapy (INOR), Pakistan is indicative of thisincidence where 51 out of 648 tests on patients withgoiter showed abnormalities of T3, T4, & TSH whichwere un-interpretable18.The most prominent alterations are lowserum triiodothyronine (T3) and elevated reverse T3(rT3), leading to the general term low T3 syndrome.Thyroid-stimulating hormone (TSH), thyroxine (T4),free T4, and free T4 index (FTI) are also affected invariable degrees based on the severity and duration ofthe NTI. As the severity of the NTI increases, bothserum T3 and T4 levels may drop and graduallynormalize as the patient recovers.Serum TSH alterations in euthyroid patientswith non thyroidal illnesses include transientlyreduced or elevated basal TSH values, blunted TSHresponse to TRH, diminished or absent diurnalrhythms of TSH, and altered TSH glycosylation andbioactivity19,20. Slightly decreased serum TSH hasbeen documented in elderly patients20, in healthycentenarians22. Food may also affect TSH secretion23.TSH levels might be considered as a sensitive markerof a lack of thyroid hormone since the concentrationsof TSH sharply increase in primary hypothyroidismeven before serum T4 and T3 fall below the normalreference range (so called sub-clinicalhypothyroidism)24. In NTIS, however, despite thedecrease in serum T3 (and T4 in severe cases), theconcentrations of TSH typically remain within low tonormal range25.Conversely, there is a blunted responseof TSH to thyrotropin-releasing hormone (TRH), andlow TSH levels are associated with poor prognosis26.Taken together, these findings suggest that a majorchange in thyroid hormone set point regulation occursin NTI. Accordingly, prolonged critically ill patientsshow diminished TSH pulsatility, characterized by anabsent nocturnal TSH surge and decreased TSH pulseamplitude27. On occasion, transient TSH elevationoccurs while the patient is still ill. Thepathophysiology of this apparent thyroid glandresistance to TSH is not clear28.Levels of T3 rapidly decrease duringstarvation e.g. post operative period or early in the courseof a critical illness. Low serum total-T3 level has beenrecognized in more than 70% of hospitalized patientswith non-thyroidal illness29. Starvation, and moreprecisely carbohydrate deprivation, appears to rapidlyinhibit deiodination of T4 to T3 by Type 1iodothyronine-deiodinase in the liver, thus inhibitinggeneration of T3, and preventing metabolism ofreverse T3, resulting in low T3 and high reverse T3concentration30. The serum concentration of reverse T3is increased innon-thyroidalillness, except in patients withrenal failure and HIV infection32.Alteration in reverse T3J Ayub Med Coll Abbottabad 2006; 18(4) 2metabolism appear to be disease specific. Both free andtotal reverse T3 levels increase as a result of reducedclearance of reverse T3, however, production rate of rT3remains normal. Reduced metabolic clearance ispredominantly due to decreased activity of the type Iiodothyronine 59-monodeiodinase (5`-MDI) intissues); 5`-MDI de-iodinates T4 to T3 and rT3 to 3,39-diiodothyronine (T2)31. Thus, serum reverse T3levels do not reliably differentiate patients witheuthyroid sick patients, and are not clinically useful32.Increased turnover of T3 and T4 in the hypermetabolic phase of illness may also contribute to lowserum and tissue T3 concentrations2. Total T3, freeT3 levels and T3 daily production rate are decreasedin non-thyroid illness33 while Total T4, free T4 anddaily production rate of T4 is normal in low T3syndrome45.Although the isolated low T3 state usuallyrepresents the mildest form of non-thyroidal illness, themagnitude of the drop in T3 level reflects the severityof illness. A very low serum T3 level has beenassociated with an increased mortality rate in patientswith hepatic cirrhosis, congestive heart failure, andother systemic dis eases35.Serum total T4 levels can be decreased (ie, low T4syndrome) typically inpatients with more chronic andsevere systemic illness36-38. Majority of patients haveserum freeT4 either being normal or slightlydecreased, but occasionally elevated39. This variabilityin free-T4 level reflects both the assay method usedand the underlying illness. As the severity of illness,progresses, there is gradual development of a morecomplex syndrome associated with low T3 and low T4levels that may correlates with the bad prognosis 40. Amarked decrease in serum T4 is associated with a highprobability of death41. Mortality rate in patients withtotal T4 level <3mg/dL was 84%; the mortality rate inpatients with T4 levels between 3 and 5 mg/dL was50%; and for those patients with T4 >5.0 mg/ dL, themortality rate was 15%42,43. Among patients with lowlevels of T4, those with very low T3 levels had theworst survival rate44.High serum total T4 is seen in situationswhere thyroid binding globulin is elevated (acuteintermittent porphyria, chronic hepatitis, and primarybiliary cirrhosis)45. T4 level is elevated, TSH level isnorma l or elevated, and T3 level is normal or high.Heparin, amiodarone and iodinated contrast agentsincrease T4 levels by inhibiting peripheral conversionof T4 to T3. In HIV multiple abnormalities have beendescribed: increased T4 and TBG, decreasedreverseT3, and normal T3 even in the setting of severeillness. Elevated levels of total and free T4 have beenreported in patients with acute psychiatric illness. 46Interpretation of bio-chemical markers ofthyroid disease in patients with goiter presenting withnon-thyroid illness is challenging. As a practicalmatter, the changes in patients with non thyroidalillness must be distinguished from those resultingfrom thyroid disease, which is often rightly suspectedin patients with other illnesses. Clinical evaluation ofthe signs and symptoms of hypothyroidism may beextremely difficult, to discern in a patient in the ICUwho typically has multiple medical problems and maybe receiving medication for sedation. Inter current

References

Van den Berghe GHA. The neuroendocrine stress

response and modem intensive care: the concept revisited,

A comprehensive and conceptual overview of new insights.

Bums 1999; 25:7-16.

Kaptein EM. The effects of systemic illness on thyroid

hormone metabolism. In: Wu SY, ed. Thyroid hormone

metabolism. Oxford: Blackwell 1991; 211-237.

Chopra IJ. Euthyroid sick syndrome: abnormalities in

circulating thyroid hormones and thyroid hormone physiology

in non-thyroid illness (NTI). Med Grand Rounds1982;1:201–

Kaplan MM, Larsen PR, Crantz FR. Prevalence of abnormal

thyroid function test results in patients with acute medical

illnesses. Am J Med 1982; 72: 9-16.

Chopra IJ, Sakane S, Teco GN. A study of the serum concentration

of tumor necrosis factor in thyroidal and non-thyroidal illnesses. J

Clin Endocrinol Metab 1991;72(5):1113-6

Hennemann G, Docter R, Krenning EP. Causes and effects of

the lowT3 syndrome during caloric deprivation and nonthyroidal illness: an overview. Acta Med Kaust 1988. 15:42–

Phillips RH, Valente WA, Caplan ES, Connor TB, Wiswell JG.

Circulating thyroid hormone changes in acute trauma:

prognostic implications for clinical outcome. J Trauma 1984.

:116 –119.

Cherem HJ, Nellen HH, Barabejski FG, Chong MBA, Lifshitz

GA. Thyroid function and abdominal surgery. A longitudinal

study. Arch Med Res 1992. 23:143–147.

J Ayub Med Coll Abbottabad 2006; 18(4)

Eber B, Schumacher M, Langsteger W, Zweiker R, Fruhwald

FM, Pokan R et al. Changes in thyroid hormone parameters

after acute myocardial infarction. Cardiology 1995. 86:152-56.

Holland FW, Brown PS, Weintraub BD, Clark RE.

Cardiopulmonary bypass and thyroid function: a “euthyroid

sick syndrome.” Ann Thorac Surg 1991. 52:46 –50.

Vexiau P, Perez-Castiglioni P, Socie G, Devergie A, Toubert

ME, Aractingi S et al. The ‘euthyroid sick syndrome:’

incidence, risk factors and prognostic value soon after allogenic

bone marrow transplantation. Br J Hematol1993; 85:778-782.

Girvent M, Maestro S, Hernandez R, Carajol I, Monne J,

Sancho JJ et al. Euthyroid sick syndrome, associated endocrine

abnormalities, and outcome in elderly patients undergoing

emergency operation. Surgery 1998;123:560-67.

Reichlin S. Neuroendocrine-immune interactions. N Eng I J

Med 1993; 3291246-53.

Chopra IJ. Clinical review 86. Euthyroid sick syndrome: is it a

misnomer? J Clin Endocrinol Metab 1997;82(2):329-34

Wartofsky L, Burman KD. Alterations in thyroid function in

patients with systemic illness: the "euthyroid sick syndrome."

EndoerRev 1982; 3:164-217

Chopra IJ. Euthyroid sick syndrome: abnormalities in

circulating thyroid hormones and thyroid hormone physiology

in non-thyroid illness (NTI). Med Grand Rounds 1982; 1:201-

Chopra IJ. Non-thyroidal illness syndrome or euthyroid sick

syndrome? Endocr Pract 1996. 2:45-52.

Thyroid Function Test Data, Institute of Nuclear Medicine,

Oncology & Radiotherapy

McIver B, Gorman CA. Euthyroid sick syndrome: An

overview. Thyroid 1997;7:125- 132.

Kaptein EM. Clinical application of free thyroxine

determinations. Clin Lab Med 1993;13:653-672

Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson

PW, Hershman JM: Low serum thyrotropin (thyroidstimulating hormone) in older persons without

hyperthyroidism. Arch Intern Med 1991; 151: 165.

Mariotti S, Barbesino G, Caturegli P, Bartalena L, Sansoni P,

Fagnoni F et al.: Complex Alteration of Thyroid Function in

Healthy Centenarians. J Clin Endocrinol Metab 1993;77: 1130.

Kamat V, Hecht WL, Rubin RT. Influence of meal composition

on the postprandial response of the pituitary-thyroid axis. Eur J

Endocrinol 1995; 133: 75.

Meier C, Trittibach P, Guglielmetti M, Staub JJ, Muller B.

Serum thyroid stimulating hormone in assessment of

severity of tissue hypothyroidism in patients with overt

primary thyroid failure: cross sectional survey. Br Med J.

;326:311-12.

Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P,

Gouwy S, Stockman W et al. Thyrotrophin and prolactin

release in prolonged critical illness: dynamics of spontaneous

secretion and effects of growth hormone-secretagogues. Clin

Endocrinol (Oxf).1997;47:599-612.

Sumita S, Ujike Y, Namiki A, Watanabe H, Kawamata M,

Watanabe A et al. Suppression of the thyrotropin response to

thyrotropin -releasing hormone and its association with severity

of critical illness. Crit Care Med 1994;22:1603-09.

Romijn JA, Wiersinga WM. Decreased nocturnal surge of

thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab

;70:35-42.

Brent GA, Hershman JM, Braunstein GD: Patients with severe

non-thyroidal illness and serum thyrotropin concentrations in

the hypothyroid range. Am J Med 1986; 81:463-66.

Van den Berghe G, de Zegher F: Anterior pituitary function

during critical illness and dopamine treatment. Crit Care Med

; 24:1580-90.

Chopra IJ, Huang TS, Beredo A, Soloman DH, Chua Teco GN.

Serum thyroid hormone binding inhibitor in nonthyroidal

illnesses. Metabolism 1986; 35:152-59.

Chopra IJ, Solomon DH, Chopra U, Wu SY, Fisher DA,

Nakamura Y. Pathways of metabolism of thyroid hormones.

Recent Prog Horm Res 1978; 34:521–67.

Burmeister LA. Reverse T3 does not reliably differentiate

hypothyroid sick syndrome from euthyroid sick syndrome.

Thyroid 1995;5:435-41.

Arem R, Wiener GJ, Kaplan SG, Kim HS, Reichlin S, Kaplan

MM. Reduced tissue thyroid hormone levels in fatal illn ess.

Metabolism 1993; 42:1102-08

Kaptein EM, Robinson WJ, Grieb DA, Nicoloff JT. Peripheral

serum thyroxine, triiodothyronine and reverse triodothyronine

kinetics in the lowthyroxine state of acute non thyroidal

illnesses. J Clin Invest 1982; 69:526 –35.

Hepner GW, Chopra IJ: Serum thyroid hormone levels in

patients with liver disease.Arch Intern Med 1979;139:111720

Kaptein EM, Grieb DA, Spencer CA, Wheeler WS, Nicoloff

JT. Thyroxine metabolism in the low thyroxine state of

critical nonthyroidal illnesses. J Clin Endocrinol Metab.

;53:764-771.

Kaptein EM, MacIntyre SS,Weiner JM, Spencer CA, Nicoloff

JT. Free thyroxine estimates in non thyroidal illness:

comparison of eight methods. J Clin Endocrinol Metab 1981;

:1073-77.

Melmed S, Geola FL, Reed AW, Pekary AE, Park J, Hershman

JM. A comparison of methods for assessing thyroid function in

non-thyroidal illness. J Clin Endocrinol Metab 1982; 54:300-

Chopra IJ, Huang TS, Beredo A, Solomon DH, Chua Teco

GN. Serum thyroid hormone binding inhibitor in

nonthyroidal illnesses. Metabolism 1986;35:152-159.

Slag MF, Morley JE, Elson MK, Crowson TW, Nettle

FQ, Shafer RB. Hypothyroxinemia in critically ill patients as

a predictor of high mortality. JAMA 1981; 245:43– 45.

Schilling JU, Zimmermann T, Albrecht S, Zwipp H, Saeger

HD. Low T3 syndromein multiple trauma patients – a

phenomenon or important pathogenetic factor? Medizinische

Klinik 1999; 3:66-69.

De Marinis L, Mancini A, Masala R, Torlontano M,

Sandric S, Barbarino A. Evaluation of pituitary-thyroid axis

response to acute myocardial infarction. J EndocrinolInvest

; 8:507

Slag MF, Morley JE, Elson MK, Crowson TW, Nuttall FQ,

Shafer RB. Hypothyroxinemia in critically ill patients as a

predictor of high mortality. JAMA 1981; 245:43-45

Brent GA, Hershman JM: Thyroxine therapy in patients with

severe non thyroidal illnesses and low serum thyroxine

concentration. J Clin Endocrinol Metab 1986; 63:1-8

Becker KL. Euthyroid sick syndrome. In: Becker KL, (Eds).

Principles and practice of endocrinology and metabolism. 2d

ed. Philadelphia: Lippincott. 1995:1786

Spratt DI, Pont A, Miller MB, McDougall IR, Bayer MF, Mc

Laughlin WT. Hyperthyroxinemia in patients with acute

psychiatric disorders. Am J Med 1982;73(1):41-8

Christ -Crain M, Meier C, Roth CB, Huber P, Staub JJ, Muller

B. Basal TSH levels compared with TRH-stimulated TSH

levels to diagnose different degrees of TSH suppression:

diagnostic and therapeutic impact of assay performance.

Eur J Clin Invest. 2002;32:931-937.

Downloads

Most read articles by the same author(s)

1 2 > >>